Robert J. Korst, MD

Chief, Oncology Surgical Services; Program Leader, Thoracic Surgery; Director, Thoracic Surgery, Valley Medical Group; Clinical Professor of Thoracic Surgery, The Icahn School of Medicine, Mount Sinai

Robert Korst, MD
Thoracic Surgery
Valley Medical Group
Member, ColigoCare
ColigoCare is a network of physicians working collectively to provide the highest quality care to patients and the community.


VMG - Thoracic Surgery

One Valley Health Plaza
Paramus, NJ 07652
Phone: 201-634-5722
Fax: 201-986-4704



B S, Fairfield University, 1981 - 1985

MD, University Of Connecticut School Of Medicine, 1985 - 1989

MBA, University Of Massachusetts, 2015 - 2017


Memorial Sloan Kettering Cancer Center, Thoracic Surgery Fellowship, 1996-1998

National Institutes of Health, Research Fellowship, 1992-1994

Internship & Residency

University of Connecticut Health Center, General Surgery Residency, 1990-1992; 1994-1996

Hartford Hospital, General Surgery Internship, 1989-1990

Board Certifications

American Board Of Surgery - Certified, 1997-present

American Board Of Thoracic Surgery - Certified, 1999-present

Get to Know Me

What is your professional experience?

My professional experience includes:

  • Attending Thoracic Surgeon, Memorial Sloan Kettering Cancer Center, 1998-2002
  • Attending Thoracic Surgeon, Weill Cornell Medical Center, 2002-2006
  • Attending Thoracic Surgeon, Valley Health System, 2007-present

What are some of the specific conditions you treat?

Lung cancer, esophageal cancer, mediastinal tumors, thymoma, barrett's esophagus, myasthenia gravis, hyperhidrosis, gastroesophageal reflux, achalasia, zenker's diverticulum, tracheal stenosis, tracheal tumors, cricopharyngeal dysphagia, pleural tumors, mesothelioma.

What techniques or procedures do you use in your practice?

Minimally invasive lung and esophageal cancer surgery, VATS lobectomy, thoracoscopic sympathectomy, endobronchial ultrasound, navigational bronchoscopy, endoscopic submucosal resection for early esophageal tumors, radiofrequency ablation for barrett's esophagus, laparoscopic hiatal hernia repair, pneumonectomy, laparoscopic heller myotomy, laparoscopic fundoplication, gastrectomy.

Describe some of your professional highlights.

A dedicated thoracic oncologic surgeon trained at Memorial Sloan-Kettering Cancer Center that also specializes in diseases of the esophagus. An active researcher with over 90 peer-reviewed publications and over 40 scientific presentations at national and international meetings. Current President of the International Thymic Malignancy Interest Group, a professional society of over 600 clinicians and researchers around the world dedicated to the study of thymic neoplasms.

Publications & Research


Analysis of Gene Expression in Peripheral Blood Mononuclear Cells in Lung Cancer
A study aimed at isolating and characterizing biomarkers for lung cancer

The Early Lung Cancer Action Program
An international consortium aimed at collecting data on the utility of low dose CT scan for screening in lung cancer

Outlier Analysis of cases with exceptional characteristics in the International Thymic Malignancy Interest Group Database
A study of cases with outlier characteristics aimed at identifying unifying characteristics of selected patients with thymic neoplasms

Clinical Trials

A Randomized Trial of Lobectomy versus Sublobar Resection for Small Peripheral Non-small Cell Lung Cancer

Adjuvant Lung Cancer Enrichment marker Identification and Sequencing Trial (ALCHEMIST)
A clinical trial aimed at determining if lung cancers express certain markers that can then be targeted with specific targeted therapies.

A Phase III, Open-label, Randomized Study to Investigate the Efficacy and Safety of MPDL3280A (anti-PD1 antibody) Compared with Best Supportive Care Following Adjuvant Cisplatin-based Chemotherapy in PDL1-selected Patients with Completely Resected Stage 1
A clinical trial investigating whether a novel antibody that enhances antitumor immunity will be useful in treating patients with lung cancer.

A multicenter, Expanded Access Program for the Treatment of patients with Advanced/Metastatic EGFR T790M Mutation-positive Non-small Cell Lung Cancer who have Received Prior EGFR TKI Therapy
A clinical trial aimed at determining if a novel EGFR inhibitor will be useful for those patients who have mutated lung cancer that have progressed through first line anti EGFR therapy.

A Randomized Comparison of Adctive Suction vs Passive Drainage and Regulated and unregulated Pleural Pressure after Anatomic Lung Resection
A clinical trial aimed at determining the best method for draining the chest following lung resection


Valley Medical Group providers accept the following plans.

Patient Ratings & Comments


Comments are gathered from our patient satisfaction surveys.

Dr Korst is very professional and tells u everything that u must know about your condition
Exceptional doctor in all respects; hope nobody I know will ever need him, but if they do - he is the one to see
This was the best medical visit I have had in my life
Doctor has been so good to me
[...] Dr. Korst took his time to explain everything to me. He is patient, kind and made me feel reassured.